Could a simple injection cut Post-Surgery painkiller use?
NCT ID NCT04260854
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tests whether injecting bupivacaine, a common numbing medication, into the surgical site after skin surgery can improve pain control. About 100 adults having skin surgery will receive either bupivacaine or a saline placebo injection. Participants will track their pain medication use for three days after surgery to see if the bupivacaine group needs fewer painkillers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine hydrochloride
- What this could lead to
- If it works, this could offer a simple way to better manage pain after skin surgery and reduce reliance on opioid painkillers.
- What could go wrong
- This is a small, early-phase pilot study, so results may not be conclusive. The benefit over standard care may be small or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University Department of Dermatology
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Can a simple pill speed up knee replacement recovery?
- A pinprick test may forecast severe pain after C-Section
- Smartphone video may read pain in a Patient's face
- Which nerve drug wins the battle against Post-Surgical knee pain?
- Could a VR headset replace pills for surgery anxiety?